Quest for the right Drug
רמיפנטניל ב.בראון 5 מ"ג REMIFENTANIL B.BRAUN 5 MG (REMIFENTANIL AS HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
אין פרטים : POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION / INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects The most common undesirable effects associated with remifentanil are direct extensions of mu-opioid agonist pharmacology. These adverse events resolve within minutes of discontinuing or decreasing the rate of remifentanil administration. The frequencies below are defined as very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000), not known (cannot be estimated from the available data). Immune System Disorders Rare: Allergic reactions including anaphylaxis have been reported in patients receiving remifentanil in conjunction with one or more anaesthetic agents. Psychiatric disorders Not known: Drug dependence Nervous System Disorders Very common: Skeletal muscle rigidity Rare: Sedation (during recovery from general anaesthesia) Not known: Convulsions Cardiac Disorders Common: Bradycardia Rare: Asystole/cardiac arrest, usually preceded by bradycardia, has been reported in patients receiving remifentanil in conjunction with other anaesthetic agents. Not known: Atrioventricular block Vascular Disorders Very common: Hypotension Common: Post-operative hypertension Respiratory, Thoracic and Mediastinal Disorders Common: Acute respiratory depression, apnoea Uncommon: Hypoxia Gastrointestinal Disorders Very common: Nausea, vomiting Uncommon: Constipation Skin and Subcutaneous Tissue Disorders Common: Pruritus General Disorders and Administration Site Conditions Common: Post-operative shivering Uncommon: Post-operative aches Not known: Drug tolerance Discontinuation of treatment Symptoms following withdrawal of remifentanil including tachycardia, hypertension and agitation have been reported infrequently upon abrupt cessation, particularly after prolonged administration of more than 3 days (see section 4.4). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form http://forms.gov.il/globaldata/getsequence/getsequence.aspx?formType=Adve rsEffectMedic@moh.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לרופא
02.12.18 - עלון לרופאעלון מידע לצרכן
לתרופה במאגר משרד הבריאות
רמיפנטניל ב.בראון 5 מ"ג